UBC researchers discover how blood vessels protect the brain during inflammation
Researchers from the University of British Columbia have discovered how blood vessels protect the brain during inflammation—a finding that could lead to the development of new treatments for neurodegenerative diseases such as stroke, epilepsy and multiple sclerosis.
Feb 21, 2019
Researchers discover how to target and disable ‘bad apple’ proteins
UBC researchers have developed a technique that targets proteins that cause disease and destroys “bad apples” in the cell.
Feb 21, 2014
Calculating the risk of stroke
UBC’s Peter Loewen discusses a new tool that offers a possible breakthrough in prevention
Nov 28, 2013
UBC heart and stroke research gets $35M boost
An unprecedented $35-million funding commitment from the Heart and Stroke Foundation to UBC will advance life-saving research and intervention programs in B.C.
Jun 25, 2013
Combination of blood thinning drugs shown to be ineffective as stroke preventer
An international team led by a neurologist at the University of British Columbia and Vancouver Coastal Health has shown that a combination of aspirin and clopidogrel, both common blood thinners, does not prevent recurrence of a common type of stroke, and may even pose serious risks.
Sep 7, 2012
New UBC professorship focuses on women's cardiovascular health
The first research program in British Columbia to focus on gender-based differences in cardiovascular disease has been established by the University of British Columbia and Providence Health Care.
Oct 19, 2011
Federal and provincial ministers break ground for UBC-VCH brain health centre
Representatives of the federal and provincial governments today marked the start of construction of a new centre at UBC that will unite brain research and patient care.
Oct 11, 2011
Anti-cholesterol drugs could help stave off seizures: UBC-Vancouver Coastal Health research
Statins, the family of drugs used to lower cholesterol, might also reduce the risk of epileptic seizures in people with cardiovascular disease, according to a new statistical study by a drug safety expert at the University of British Columbia and Vancouver Coastal Health Research Institute. The findings could provide the basis for randomized, controlled clinical trials to test the efficacy of the drugs as anti-epileptic medication.
Oct 25, 2010